Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

Ann Med Res. 2014; 21(1): 71-73


The Use of Rocuronium With Suggammadex in Electroconvulsive Therapy of the Patient With Neuroleptic Malignant Syndrome: Case Report

Mukadder Şanlı, Hüseyin İlksen Toprak, Ülkü Özgül, Nizamettin Bucak, M. Özcan Ersoy

.




Abstract


Neuroleptic malignant syndrome often occurs as a side effect of antipsychotic drugs. The syndrome is characterized by altered consciousness, hemodynamic instability, fever, muscle rigidity and susceptibility to malignant hyperthermia therefore anesthetic management is important. Electroconvulsive therapy used to in the treatment of psychotic symptoms with neuroleptic malignant syndrome. Succinylcholine is used as a muscle relaxant in the electroconvulsive therapy. Succinylcholine should be used cautiously in patients with suspected malignant hyperthermia. Suggammadex that antagonized of non-depolarizing muscle relaxants is used as easy and safe increasingly in recent years. This case report describes the use of rocuronium-sugammadex accompanied with literature for the anesthetic management of neuroleptic malignant syndrome.

Key Words: Neuroleptic Malignant Syndrome; Electroconvulsive Therapy; Malignant Hyperthermia; Suggammadex






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.